Facebook co-founder Sean Parker is donating $250 million to cancer immunotherapy research at several hospitals. Dr. Jedd Wolchok, of Memorial Sloan-Kettering Cancer Center and patient Mary Elizabeth Williams explain the importance of this research .
Cancer immunotherapy will get a hefty dose of its own moonshot Wednesday when a tech billionaire announces he's giving $250 million to six cancer centers nationwide, including Manhattan's Memorial Sloan Kettering and Stanford.
Sean Parker, founder of the music file-sharing service Napster and the founding president of Facebook, says he is putting his money behind cancer immune therapy because it is at a turning point and would benefit from research that is done without regard for the costs.
Immunotherapy, which enhances the body's immune system to kill cancer cells, is best known these days because former president Jimmy Carter was on an immune-based drug treatment when he announced in December that there is no detectable cancer in his body.
No comments:
Post a Comment